Metastasis (CNIO-CaixaResearch Frontiers Meeting)

Metastasis (CNIO-CaixaResearch Frontiers Meeting)

CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS - CNIO Auditorio - Madrid - España

CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS - CNIO y FUNDACIÓN LA CAIXA

Julio Aguirre-Ghiso, Albert Einstein College of Medicine, US
Caroline Dive, Cancer Research UK Manchester Institute, UK
Eva González-Suarez, Spanish National Cancer Research Centre – CNIO, Spain
Héctor Peinado, Spanish National Cancer Research Centre – CNIO, Spain
Manuel Valiente, Spanish National Cancer Research Centre – CNIO, Spain

Speakers:
Nicola Aceto, ETH Zurich, Switzerland
Judith Agudo, Dana-Farber Cancer Institute, US
Julio Aguirre-Ghiso, Albert Einstein College of Medicine, US
Salvador Aznar-Benitah, Institute of Biomedical Research (IRB), Spain
Eduard Batlle, Institute of Biomedical Research (IRB), Spain
Adrienne Boire, Memorial Sloan Kettering Cancer Center, US
Jeremy C. Borniger, Cold Spring Harbor Laboratory, US
Shang Cai, Westlake University, China
Carlos Caldas, Cancer Research UK Cambridge Institute, UK
Caroline Dive, Cancer Research UK Cambridge Institute, UK
Mikala Egeblad, Cold Spring Harbor Laboratory, US
Edgar G Engleman, Stanford University, US
Sarah-Maria Fendt, VIB KU Leuven Center for Cancer Biology, Belgium
Cyrus Ghajar, Fred Hutchinson Cancer Center, US
Claudia Gravekamp, Albert Einstein College of Medicine, US
Johanna Joyce, Ludwig Institute for Cancer Research, Switzerland
Jean-Christophe Marine, Leuven Center for Cancer Biology, Belgium
Maria Rescigno, Humanitas University, Italy
Erik Sahai, The Francis Crick Institute, UK
Erica Sloan, Victorian Heart Institute (VHI), Monash University, Australia
Marisol Soengas, Spanish National Cancer Research Centre - CNIO, Spain
Humsa Venkatesh, Dana-Farber/Harvard Cancer Center, US
Alana Welm, The University of Utah, US
Frank Winkler, University Hospital Heidelberg and German Cancer Research Center, Germany
Xiang Zhang, Baylor College of Medicine, US

CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS

917 328 000

meetings@cnio.es

https://www.cnio.es/en/eventos/cnio-caixaresearch-frontiers-meeting-metastasis-2/

Metastasis is the main driving force for cancer-associated lethality as they are more difficult to treat than primary tumors. The exponential increase in heterogeneity throughout the metastatic cascade and the underlying biology that involves the generation of novel ecosystems incorporating resident and peripheral components of the microenvironment might explain the increased ability to resist therapies. The CNIO Frontier meeting will provide the most up-to-date perspective on metastasis including the best ways to model metastasis, embrace its heterogeneity, prevent metastases from happening, exploit organ-specific survival mechanism of cancer cells among other key topics. These novel research findings will be contributed by leaders in the field, which will make the CNIO Frontier Meeting on Metastasis the most relevant cancer research forum of the year.

Topics to be covered:

• Modelling Evolution of Metastasis
• Non-Genetic Adaptation in Metastasis (Metabolism, Epigenetics and Stress)
• Microorganismal Influence on Metastasis
• Anti-Metastasis Therapies and Clinical
• Influence of Microenvironment in Metastasis
• CTCS/ DTC/ CTDNA: New Technologies and Implications
• Neurobiology of Metastasis

Abstracts:

Abstract submission deadline September 25, 2023
Abstracts must be submitted online when you register.

Top scoring abstracts will be selected for short talks in the main programme
Abstract Title (max. 50 words) / Abstract Authors (max. 100 words) / Abstract Centres/Organisations (max. 100 words) / Abstract (max. 450 words including references)

Registration and Payment:

200 Euro Students and CNIO staff; 400 Euro Post-docs and Academia; 600 Euro Industry
Register now